Streptomycin

Overview

Streptomycin is an antibiotic medication used to treat a number of bacterial infections, including tuberculosis, Mycobacterium avium complex, endocarditis, brucellosis, Burkholderia infection, plague, tularemia, and rat bite fever. For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. It is administered by injection into a vein or muscle.[1][2] WP

Common side effects include vertigo, vomiting, numbness of the face, fever, and rash. Use during pregnancy may result in permanent deafness in the developing baby. Use appears to be safe while breastfeeding. It is not recommended in people with myasthenia gravis or other neuromuscular disorders. Streptomycin is an aminoglycoside. It works by blocking the ability of 30S ribosomal subunits to make proteins, which results in bacterial death.[1][2] WP

Albert Schatz first isolated streptomycin in 1943 from Streptomyces griseus. It is on the World Health Organization's List of Essential Medicines. The World Health Organization classifies it as critically important for human medicine.[3–6] WP

Uses, dosage and effects

Medication

• Infective endocarditis: An infection of the endocardium caused by enterococcus; used when the organism is not sensitive to gentamicin WP⚠ Part of this sentence could not be copied from the source. Open the source to read it in full.
• Tuberculosis: Used in combination with other antibiotics. For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. It is not the first-line treatment, except in medically under-served populations where the cost of more expensive treatments is prohibitive. It may be useful in cases where resistance to other drugs is identified.[2] WP⚠ Part of this sentence could not be copied from the source. Open the source to read it in full.
• Plague (Yersinia pestis): Has historically been used as the first-line treatment. However streptomycin is approved for this purpose only by the US Food and Drug Administration. WP⚠ Part of this sentence could not be copied from the source. Open the source to read it in full.
• In veterinary medicine, streptomycin is the first-line antibiotic for use against gram negative bacteria in large animals (horses, cattle, sheep, etc.). It is commonly combined with procaine penicillin for intramuscular injection. WP⚠ Part of this sentence could not be copied from the source. Open the source to read it in full.
• Tularemia infections have been treated mostly with streptomycin.[7] WP

Streptomycin is traditionally given intramuscularly, and in many nations is only licensed to be administered intramuscularly, though in some regions the drug may also be administered intravenously.[8] WP

Pesticide

Streptomycin is also used as a pesticide, to combat the growth of bacteria. Streptomycin controls bacterial diseases of certain fruit, vegetables, seed, and ornamental crops. A major use is in the control of fireblight on apple and pear trees. As in medical applications, extensive use can be associated with the development of resistant strains. Streptomycin could potentially be used to control cyanobacterial blooms in ornamental ponds and aquaria. While some antibacterial antibiotics are inhibitory to certain eukaryotes, this seems not to be the case for streptomycin, especially in the case of anti-fungal activity.[9][10] WP

Cell culture

Streptomycin, in combination with penicillin, is used in a standard antibiotic cocktail to prevent bacterial infection in cell culture.[11] WP

Protein purification

When purifying protein from a biological extract, streptomycin sulfate is sometimes added as a means of removing nucleic acids and ribonuclear proteins. Since it binds to ribosomes and precipitates out of solution, it serves as a method for removing rRNA, mRNA, and even DNA if the extract is from a prokaryote.[12] WP

Risks and side effects

Side effects

The most concerning side effects, as with other aminoglycosides, are kidney toxicity and ear toxicity. Transient or permanent deafness may result. The vestibular portion of cranial nerve VIII (the vestibulocochlear nerve) can be affected, resulting in tinnitus, vertigo, ataxia, kidney toxicity, and can potentially interfere with diagnosis of kidney malfunction.[13][14] WP

Common side effects include vertigo, vomiting, numbness of the face, fever, and rash. Fever and rashes may result from persistent use. WP⚠ Wikipedia itself has flagged this text: citation needed.

Use is not recommended during pregnancy. Congenital deafness has been reported in children whose mothers received streptomycin during pregnancy. Use appears to be okay while breastfeeding.[1][2] WP

It is not recommended in people with myasthenia gravis.[2] WP

Pharmacology

Mechanism of action

Streptomycin functions as a protein synthesis inhibitor. It binds to the small 16S rRNA of the 30S ribosomal subunit irreversibly, interfering with the binding of formyl-methionyl-tRNA to the 30S subunit. This causes codon misreading, inhibition of protein synthesis, and ultimately death of the cell through mechanisms that are not well understood. Speculation indicates that the binding of the molecule to the 30S subunit interferes with 30S subunit association with the mRNA strand. This results in an unstable ribosomal-mRNA complex, leading to premature stopping of protein synthesis, leading to cell death. As human and bacteria both have ribosomes, streptomycin has significant side effects in humans. At low concentrations, however, streptomycin inhibits only bacterial growth.[15][16][17] WP

Streptomycin is an antibiotic that inhibits both Gram-positive and Gram-negative bacteria, and is therefore a useful broad-spectrum antibiotic. However, bacteria may add adenyl groups to streptomycin, destroying it.[18][19] WP

History

History

Streptomycin was first isolated on October 19, 1943, by Albert Schatz, a PhD student in the laboratory of Selman Abraham Waksman at Rutgers University in a research project funded by Merck and Co. Waksman and his laboratory staff discovered several antibiotics, including actinomycin, clavacin, streptothricin, streptomycin, grisein, neomycin, fradicin, candicidin, and candidin. Of these, streptomycin and neomycin found extensive application in the treatment of numerous infectious diseases. Streptomycin was the first antibiotic cure for tuberculosis (TB). In 1952 Waksman was the recipient of the Nobel Prize in Physiology or Medicine in recognition "for his discovery of streptomycin, the first antibiotic active against tuberculosis". Waksman was later accused of playing down the role of Schatz who did the work under his supervision, claiming that Elizabeth Bugie had a more important role in its development. Schatz sued both Dr. Waksman and the Rutgers Research and Endowment Foundation, wanting to be given credit as co-discover and to receive the royalties for the streptomycin. By the end of the settlement, Waksman would receive a 10% royalty, while Schatz got 3% and compensation for his missed royalties. The rest of the lab shared the remaining 7% of the royalties, in which Bugie received 0.2%.[20–28] WP⚠ Wikipedia itself has flagged this text: citation needed.

Bugie was pursuing a master's degree in Waksman's lab at Rutgers University at this time. Prior to this, she received her bachelor's degree in microbiology at New Jersey College for Women. Although Bugie was considered to be the second author on the Proceedings of the Society for Experimental Biology paper, she was not listed on the patent submission. Bugie's contributions to Waksman's lab were great. In addition to her work on streptomycin, she also helped develop other antimicrobial substances, had two peer-reviewed publications, and researched the use of antimicrobials against plant pathogens, among several other important contributions to the scientific field, particularly in regard to microbiology.[27][29–32] WP

The Rutgers team reported streptomycin in the medical literature in January 1944. Within months they began working with William Feldman and H. Corwin Hinshaw of the Mayo Clinic with hopes of starting a human clinical trial of streptomycin in tuberculosis. The difficulty at first was even producing enough streptomycin to do a trial, because the research laboratory methods of creating small batches had not yet been translated to commercial large-batch production. They managed to do an animal study in a few guinea pigs with just 10 grams of the scarce drug, demonstrating survival. This was just enough evidence to get Merck & Co. to divert some resources from the young penicillin production program to start work toward streptomycin production.[33][34] WP

At the end of World War II, the United States Army experimented with streptomycin to treat life-threatening infections at a military hospital in Battle Creek, Michigan. The first person who was treated with streptomycin did not survive; the second person survived but became blind as a side effect of the treatment. In March 1946, the third person—Robert J. Dole, later Majority Leader of the United States Senate and presidential nominee—experienced a rapid and robust recovery.[35] WP

The first randomized trial of streptomycin against pulmonary tuberculosis was carried out in 1946 through 1948 by the MRC Tuberculosis Research Unit under the chairmanship of Geoffrey Marshall (1887–1982). The trial was neither double-blind nor placebo-controlled. It is widely accepted to have been the first randomized curative trial.[36][37] WP

Results showed efficacy against TB, albeit with minor toxicity and acquired bacterial resistance to the drug.[36] WP

New jersey

Because streptomycin was isolated from a microbe discovered on New Jersey soil, and because of its activity against tuberculosis and Gram negative organisms, and in recognition of both the microbe and the antibiotic in the history of New Jersey, S. griseus was nominated as the Official New Jersey state microbe. The draft legislation was submitted by Senator Sam Thompson (R-12) in May 2017 as bill S3190 and Assemblywoman Annette Quijano (D-20) in June 2017 as bill A31900. The bill was passed on 2018-01-08 The bill designates Streptomyces griseus as New Jersey State Microbe (New Jersey Senate Bill 3190 (2017). Governor Phil Murphy signed the bill making it official in 2019.[38] WP

Chemistry

Formula

C21H39N7O12 PC

CAS number

57-92-1 PC

Molar mass (g/mol)

581.6 PC

IUPAC name (computed by PubChem)

2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine PC

SMILES

C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O PC

InChIKey

UCSJYZPVAKXKNQ-HZYVHMACSA-N PC

PubChem CID

19649

Harm reduction information

No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.

User reports

Pop culture

No references added yet.

Sources

1. Other Streptomycin Sulfate
2. Other WHO Model Formulary 2008. 2009
3. Other Torok E, Moran E, Cooke F. Oxford Handbook of Infectious Diseases and Microbiology. 2009
4. Other Renneberg R, Demain AL. Biotechnology for Beginners. 2008
5. Other World Health Organization model list of essential medicines: 21st list 2019. 2019
6. Other Critically important antimicrobials for human medicine. 2019
7. Journal / agency Clinicians Tularemia. September 2016
8. Journal / agency Zhu M, Burman WJ, Jaresko GS, Berning SE, Jelliffe RW, Peloquin CA. Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis. Pharmacotherapy. September 2001. doi:10.1592/phco.21.13.1037.34625 · PMID 11560193
9. Journal / agency Qian H, Li J, Pan X, Sun Z, Ye C, Jin G, Fu Z. Effects of streptomycin on growth of algae Chlorella vulgaris and Microcystis aeruginosa. Environmental Toxicology. March 2012. doi:10.1002/tox.20636 · PMID 20725941
10. Journal / agency Reilly HC, Schatz A, Waksman SA. Antifungal Properties of Antibiotic Substances. Journal of Bacteriology. June 1945. doi:10.1128/jb.49.6.585-594.1945 · PMID 16560957 · PMC374091
11. Journal / agency Phelan K, May KM. Basic techniques in mammalian cell tissue culture. Current Protocols in Cell Biology. March 2015. doi:10.1002/0471143030.cb0101s66 · PMID 25727327
12. Other Scopes RK. Protein purification: principles and practice. 1994
13. Journal / agency Prayle A, Watson A, Fortnum H, Smyth A. Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis. Thorax. July 2010. doi:10.1136/thx.2009.131532 · PMID 20627927 · PMC2921289
14. Journal / agency Syal K, Srinivasan A, Banerjee D. Streptomycin interference in Jaffe reaction - possible false positive creatinine estimation in excessive dose exposure. Clinical Biochemistry. January 2013. doi:10.1016/j.clinbiochem.2012.10.031 · PMID 23123914
15. Journal / agency Sharma D, Cukras AR, Rogers EJ, Southworth DR, Green R. Mutational analysis of S12 protein and implications for the accuracy of decoding by the ribosome. Journal of Molecular Biology. December 2007. doi:10.1016/j.jmb.2007.10.003 · PMID 17967466 · PMC2200631
16. Other Raymon LP. COMLEX Level 1 Pharmacology Lecture Notes. 2011
17. Other Voet D, Voet JG. Biochemistry. 2004
18. Other Schantz JT, Ng KW. A manual for primary human cell culture. 2004
19. Other McGraw-Hill encyclopedia of science & technology. 2012
20. Journal / agency Comroe JH. Pay dirt: the story of streptomycin. Part I. From Waksman to Waksman. The American Review of Respiratory Disease. April 1978. doi:10.1164/arrd.1978.117.4.773 · PMID 417651
21. Journal / agency Kingston W. Streptomycin, Schatz v. Waksman, and the balance of credit for discovery. Journal of the History of Medicine and Allied Sciences. July 2004. doi:10.1093/jhmas/jrh091 · PMID 15270337
22. Other All Nobel Prizes in Physiology or Medicine
23. Other Obiturary: Elizabeth Gregory / Did McCandless woman get fair shake for role in discovery of streptomycin?
24. Other Wainwright M. Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics. 1990
25. Journal / agency Wainwright M. Streptomycin: discovery and resultant controversy. History and Philosophy of the Life Sciences. 1991. PMID 1882032
26. Other Pringle P. Experiment Eleven: Dark Secrets Behind the Discovery of a Wonder Drug. 2012
27. Other Elizabeth Bugie – the invisible woman in the discovery of streptomycin
28. Other The Forgotten Women of the Antibiotics Race. July 22, 2021
29. Journal / agency Women in Microbiology. 2018. doi:10.1128/9781555819545
30. Journal / agency Waksman SA, Bugie E. Strain Specificity and Production of Antibiotic Substances: II. Aspergillus Flavus-Oryzae Group. Proceedings of the National Academy of Sciences of the United States of America. September 1943. doi:10.1073/pnas.29.9.282 · PMID 16578091 · PMC1078613
31. Journal / agency Waksman SA, Bugie E. Chaetomin, a New Antibiotic Substance Produced by Chaetomium cochliodes: I. Formation and Properties. Journal of Bacteriology. November 1944. doi:10.1128/jb.48.5.527-530.1944 · PMID 16560863 · PMC374002
32. Journal / agency Waksman SA, Bugie E. Action of Antibiotic Substances Upon Ceratostotnella ulmi. Experimental Biology and Medicine. October 1, 1943. doi:10.3181/00379727-54-14310
33. Journal / agency Schatz A, Bugle E, Waksman SA. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Experimental Biology and Medicine. 1944. doi:10.3181/00379727-55-14461
34. Other Ryan F. The forgotten plague: how the battle against tuberculosis was won—and lost. 1993
35. Other Cramer RB. What it takes: the way to the White House. 1992
36. Journal / agency D'Arcy Hart P. A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s. BMJ. August 1999. doi:10.1136/bmj.319.7209.572 · PMID 10463905 · PMC1116443
37. Journal / agency Metcalfe NH. Sir Geoffrey Marshall (1887-1982): respiratory physician, catalyst for anaesthesia development, doctor to both Prime Minister and King, and World War I Barge Commander. Journal of Medical Biography. February 2011. doi:10.1258/jmb.2010.010019 · PMID 21350072
38. Other New Jersey gets official state microbe: Streptomyces griseus. May 11, 2019

Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.